Volume 21 Issue 12
Dec.  2023
Turn off MathJax
Article Contents
WEI Xiaofang, CHEN Qiaolin, FENG Youfan, FU Yuan, LIU Fei, ZHANG Wenjie, CHEN Yang, ZHAO Yangyang, HUANG Xiujuan, ZHANG Qike. Functional and mechanistic of TCF3 regulating linc00152 on carcinogenic effects in Burkitt's lymphoma[J]. Chinese Journal of General Practice, 2023, 21(12): 2045-2048. doi: 10.16766/j.cnki.issn.1674-4152.003286
Citation: WEI Xiaofang, CHEN Qiaolin, FENG Youfan, FU Yuan, LIU Fei, ZHANG Wenjie, CHEN Yang, ZHAO Yangyang, HUANG Xiujuan, ZHANG Qike. Functional and mechanistic of TCF3 regulating linc00152 on carcinogenic effects in Burkitt's lymphoma[J]. Chinese Journal of General Practice, 2023, 21(12): 2045-2048. doi: 10.16766/j.cnki.issn.1674-4152.003286

Functional and mechanistic of TCF3 regulating linc00152 on carcinogenic effects in Burkitt's lymphoma

doi: 10.16766/j.cnki.issn.1674-4152.003286
Funds:

 21JR1RA023

  • Received Date: 2023-04-18
    Available Online: 2024-01-29
  •   Objective  To investigate the function and mechanism of TCF3 in regulating proliferation and apoptosis of Daudi and Raji cells through linc00152.  Methods  The interference efficiency of linc00152 was detected by real-time quantitative polymerase chain reaction (qPCR). CCK8, Western blotting, and flow cytometry were used to detect the effects of linc00152 on the proliferation and apoptosis of Daudi and Raji cells. ChIP-PCR detected the binding of TCF3 to the promoter region of linc00152. qPCR and Western blotting were used to detect the interference efficiency of TCF3. qPCR was used to detect the effect of TCF3 on the expression level of linc00152.  Results  siRNA successfully interfered with the expression of linc00152 in Daudi and Raji cells. CCK8 results showed that interference of linc00152 could inhibit the proliferation of Daudi and Raji cells, while Western blotting and flow cytometry results showed that interference of linc00152 could promote cell apoptosis (Daudi: 35.30±2.84 vs. 6.95±0.82; Raji: 33.17±2.18 vs. 6.47±0.38). ChIP-PCR results showed that TCF3 could bind to the promoter of linc00152. The results of qPCR and Western blotting showed that both the mRNA and protein levels of TCF3 could be successfully interfered by siRNA. In Daudi and Raji cells, si-TCF3 could reduce the expression of linc00152 (Daudi: 0.509±0.048 vs. 0.906± 0.146; Raji: 0.502±0.052 vs. 0.966±0.103).  Conclusion  Linc00152 can promote the proliferation of Daudi and Raji cells and inhibit apoptosis, which may be related to the regulation of linc00152 by TCF3.

     

  • loading
  • [1]
    刘文凤, 邓欢, 颉鸿笙, 等. 伯基特淋巴瘤发病机制的研究进展[J]. 中国比较医学杂志, 2019, 29(10): 122-125.

    LIU W F, DENG H, JIE H S, et al. Research advances in pathogenesis of Burkitt lymphoma[J]. Chinese Journal of Comparative Medicine, 2019, 29(10): 122-125.
    [2]
    CROMBIE J, LACASCE A. The treatment of Burkitt lymphoma in adults[J]. Blood, 2021, 137(6): 743-750. doi: 10.1182/blood.2019004099
    [3]
    PANEA R I, LOVE C L, SHINGLETON J R, et al. The whole-genome landscape of Burkitt lymphoma subtypes[J]. Blood, 2019, 134(19): 1598-1607. doi: 10.1182/blood.2019001880
    [4]
    TAN Y T, LIN J F, LI T, et al. LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer[J]. Cancer Commun(Lond), 2021, 41(2): 109-120.
    [5]
    钟剑锋, 钟莉莉, 于双. LncRNA与肿瘤关系的研究进展[J]. 中国实验诊断学, 2022, 26(6): 930-933.

    ZHONG J F, ZHONG L L, YU S. Research progress on the relationship between LncRNA and tumor[J]. Chinese Journal of Laboratory Diagnosis, 2022, 26(6): 930-933.
    [6]
    程先硕, 杨之斌, 董坚. 缺氧诱导的lncRNA与肿瘤免疫逃逸[J]. 中国肿瘤生物治疗杂志, 2022, 29(10): 871-878.

    CHENG X S, YANG Z B, DONG J. Hypoxia induced lncRNAs and tumor immune escape[J]. Chinese Journal of Cancer Biotherapy, 2022, 29(10): 871-878.
    [7]
    PELLEGRINO R, CASTOLDI M, TICCONI F, et al. LINC00152 drives a competing endogenous RNA network in human hepatocellular carcinoma[J]. Cells, 2022, 11(9): 1528. doi: 10.3390/cells11091528
    [8]
    OU C L, SUN Z Q, HE X Y, et al. Targeting YAP1/LINC00152/FSCN1 signaling axis prevents the progression of colorectal cancer[J]. Adv Sci(Weinh), 2020, 7(3): 1901380. DOI: 10.1002/advs.201901380.
    [9]
    WU Y, TAN C, WENG W W, et al. Long non-coding RNA Linc00152 is a positive prognostic factor for and demonstrates malignant biological behavior in clear cell renal cell carcinoma[J]. Am J Cancer Res, 2016, 6(2): 285-299.
    [10]
    HU H, CHEN C, CHEN F G, et al. LINC00152 knockdown suppresses tumorigenesis in non-small cell lung cancer via sponging miR-16-5p[J]. J Thorac Dis, 2022, 14(3): 614-624. doi: 10.21037/jtd-22-59
    [11]
    MAO Y, TIE Y, DU J, et al. LINC00152 promotes the proliferation of gastric cancer cells by regulating B-cell lymphoma-2[J]. J Cell Biochem, 2019, 120(3): 3747-3756. doi: 10.1002/jcb.27655
    [12]
    董丽华, 黄静静, 刘静, 等. TCF3在伯基特淋巴瘤中的表达、增殖作用和预后意义[J]. 中国实验血液学杂志, 2022, 30(5): 1435-1439.

    DONG L H, HUANG J J, LIU J, et al. Expression of TCF3 in Burkitt's lymphoma and its proliferative effect and prognostic significance[J]. Journal of Experimental Hematology, 2022, 30(5): 1435-1439.
    [13]
    SHI Y, DING D H, QU R F, et al. Non-coding RNAs in diffuse large B-cell lymphoma[J]. Onco Targets Ther, 2020, 13: 12097-12112. doi: 10.2147/OTT.S281810
    [14]
    GUO C, GONG M, LI Z L. Knockdown of lncRNA MCM3AP-AS1 attenuates chemoresistance of burkitt lymphoma to doxorubicin treatment via targeting the miR-15a/EIF4E axis[J]. Cancer Manag Res, 2020, 12: 5845-5855. doi: 10.2147/CMAR.S248698
    [15]
    WINKLE M, TAYARI M M, KOK K, et al. The lncRNA KTN1-AS1 co-regulates a variety of Myc-target genes and enhances proliferation of Burkitt lymphoma cells[J]. Hum Mol Genet, 2022, 31(24): 4193-4206. doi: 10.1093/hmg/ddac159
    [16]
    MAO S D, JIN J P, LI Z, et al. Knockdown of long non-coding RNA ANRIL inhibits the proliferation and promotes the apoptosis of Burkitt lymphoma cells through the TGF-β1 signaling pathway[J]. Mol Med Rep, 2021, 23(2): 146.
    [17]
    ZHENG C L, XIAO Y, LI Y Q, et al. Knockdown of long non-coding RNA PVT1 inhibits the proliferation of Raji cells through cell cycle regulation[J]. Oncol Lett, 2019, 18(2): 1225-1234.
    [18]
    LIU G, YANG Z F, SUN J, et al. The LINC00152/miR-205-5p/CXCL11 axis in hepatocellular carcinoma cancer-associated fibroblasts affects cancer cell phenotypes and tumor growth[J]. Cell Oncol(Dordr), 2022, 45(6): 1435-1449. doi: 10.1007/s13402-022-00730-4
    [19]
    ZHANG J M, YIN M N, HUANG J M, et al. Long noncoding RNA LINC00152 as a novel predictor of lymph node metastasis and survival in human cancer: a systematic review and meta-analysis[J]. Clin Chim Acta, 2018, 483: 25-32. doi: 10.1016/j.cca.2018.03.034
    [20]
    ZHENG L L, HU N, ZHOU X Z. TCF3-activated LINC00152 exerts oncogenic role in osteosarcoma through regulating miR-1182/CDK14 axis[J]. Pathol Res Pract, 2019, 215(2): 373-380. doi: 10.1016/j.prp.2018.12.031
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(5)  / Tables(2)

    Article Metrics

    Article views (161) PDF downloads(8) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return